PubRank

Haiden A Huskamp

Author PubWeight™ 85.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med 2009 6.46
2 Behavioral health insurance parity for federal employees. N Engl J Med 2006 3.77
3 Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol 2013 3.70
4 Physician factors associated with discussions about end-of-life care. Cancer 2010 3.54
5 Moving beyond parity--mental health and addiction care under the ACA. N Engl J Med 2011 2.20
6 End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med 2012 2.08
7 Association between the Part D coverage gap and adverse health outcomes. J Am Geriatr Soc 2012 1.99
8 Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol 2012 1.95
9 Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review. Med Care 2012 1.91
10 New Jersey's efforts to improve postpartum depression care did not change treatment patterns for women on medicaid. Health Aff (Millwood) 2011 1.83
11 Physical and mental health status of older long-term cancer survivors. J Am Geriatr Soc 2005 1.82
12 Medicare Part D and nursing home residents. J Am Geriatr Soc 2007 1.74
13 A political history of federal mental health and addiction insurance parity. Milbank Q 2010 1.70
14 Intended and unintended consequences of the gabapentin off-label marketing lawsuit among patients with bipolar disorder. J Clin Psychiatry 2012 1.48
15 Aligning incentives in the treatment of depression in primary care with evidence-based practice. Psychiatr Serv 2003 1.39
16 Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage. JAMA 2011 1.36
17 Whom do older adults trust most to provide information about prescription drugs? Am J Geriatr Pharmacother 2009 1.36
18 The effects of mental health parity on spending and utilization for bipolar, major depression, and adjustment disorders. Am J Psychiatry 2013 1.34
19 Impact of full mental health and substance abuse parity for children in the Federal Employees Health Benefits Program. Pediatrics 2007 1.33
20 Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. Am J Geriatr Psychiatry 2010 1.32
21 Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap. PLoS Med 2011 1.26
22 How the new medicare drug benefit could affect vulnerable populations. Health Aff (Millwood) 2006 1.21
23 Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010. Acad Pediatr 2012 1.15
24 Dual eligibles with mental disorders and Medicare part D: how are they faring? Health Aff (Millwood) 2009 1.11
25 The impact of parity on major depression treatment quality in the Federal Employees' Health Benefits Program after parity implementation. Med Care 2006 1.09
26 Case-mix adjustment of consumer reports about managed behavioral health care and health plans. Health Serv Res 2008 1.05
27 Racial variation in willingness to trade financial resources for life-prolonging cancer treatment. Cancer 2011 1.04
28 Differences in hospice care between home and institutional settings. J Palliat Med 2007 0.99
29 Longitudinal racial/ethnic disparities in antimanic medication use in bipolar-I disorder. Med Care 2009 0.98
30 Use of prescription drug samples and patient assistance programs, and the role of doctor-patient communication. J Gen Intern Med 2011 0.97
31 Characteristics of adults with substance use disorders expected to be eligible for Medicaid under the ACA. Psychiatr Serv 2013 0.95
32 Potential savings from an evidence-based consumer-oriented public education campaign on prescription drugs. Health Serv Res 2008 0.95
33 Medicare part D and the nursing home setting. Gerontologist 2008 0.93
34 Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010. Breast Cancer Res Treat 2012 0.92
35 The influence of Medicare home health payment incentives: does payer source matter? Inquiry 2006 0.90
36 Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory. Pharmacoepidemiol Drug Saf 2012 0.89
37 Physicians' propensity to discuss prognosis is associated with patients' awareness of prognosis for metastatic cancers. J Palliat Med 2014 0.89
38 Quality of care in a Medicaid population with bipolar I disorder. Psychiatr Serv 2007 0.88
39 Racial and ethnic disparities in postpartum depression care among low-income women. Psychiatr Serv 2011 0.87
40 Financial status, employment, and insurance among older cancer survivors. J Gen Intern Med 2009 0.87
41 Using performance data to identify preferred hospitals. Health Serv Res 2007 0.86
42 Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008. Psychiatr Serv 2013 0.86
43 Beneficiaries with cardiovascular disease and thePart D coverage gap. Circ Cardiovasc Qual Outcomes 2012 0.85
44 High-deductible health plans and costs and utilization of maternity care. Am J Manag Care 2011 0.84
45 Effect of Part D coverage restrictions for antidepressants, antipsychotics, and cholinesterase inhibitors on related nursing home resident outcomes. J Am Geriatr Soc 2014 0.84
46 Ownership status and home health care performance. J Aging Soc Policy 2009 0.84
47 Changes in physician antipsychotic prescribing preferences, 2002-2007. Psychiatr Serv 2014 0.84
48 The impact of emerging safety and effectiveness evidence on the use of physician-administered drugs: the case of bevacizumab for breast cancer. Med Care 2013 0.83
49 Angiotensin receptor blockers on the formularies of Medicare drug plans. J Gen Intern Med 2007 0.83
50 Economic grand rounds: the price is right? Changes in the quantity of services used and prices paid in response to parity. Psychiatr Serv 2012 0.82
51 Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research: An Observational Study of the Effectiveness of Mental Health Parity. Stat Biosci 2011 0.82
52 Medicare Part D claims rejections for nursing home residents, 2006 to 2010. Am J Manag Care 2012 0.82
53 Who Were the Early Adopters of Dabigatran?: An Application of Group-based Trajectory Models. Med Care 2016 0.81
54 The health value and cost of care for major depression. Value Health 2009 0.80
55 A Prescription for Drug Formulary Evaluation: An Application of Price Indexes. Forum Health Econ Policy 2012 0.79
56 Effects of Medicare Part D on guideline-concordant pharmacotherapy for bipolar I disorder among dual beneficiaries. Psychiatr Serv 2014 0.79
57 Medicaid medication access problems and increased psychiatric hospital and emergency care. Gen Hosp Psychiatry 2010 0.78
58 Cost-effectiveness analysis of short-term clopidogrel therapy for ST elevation myocardial infarction. Crit Pathw Cardiol 2010 0.77
59 Diffusion of antipsychotics in the US And French markets, 1998-2008. Psychiatr Serv 2013 0.77
60 Parity and out-of-pocket spending for children with high mental health or substance abuse expenditures. Pediatrics 2013 0.77
61 Antipsychotic prescribing: do conflict of interest policies make a difference? Med Care 2015 0.77
62 Response letter to Eltonsy and colleagues. J Am Geriatr Soc 2013 0.75
63 Regional Variation in Physician Adoption of Antipsychotics: Impact on US Medicare Expenditures. J Ment Health Policy Econ 2016 0.75
64 High-risk medication use by nursing home residents before and after hospitalization. Med Care 2014 0.75
65 Patient, Physician and Organizational Influences on Variation in Antipsychotic Prescribing Behavior. J Ment Health Policy Econ 2016 0.75
66 Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophrenia. Psychiatr Serv 2013 0.75
67 Uninsurance and its correlates among poor adults with disabilities. J Health Care Poor Underserved 2012 0.75
68 The Effects of the Transition From Medicaid to Medicare on Health Care Use for Adults With Mental Illness. Med Care 2016 0.75
69 Lessons for healthcare reform from the hard-won success of behavioral health insurance parity. Am J Psychiatry 2009 0.75
70 Effects of Global Payment and Accountable Care on Medication Treatment for Alcohol and Opioid Use Disorders. J Addict Med 2017 0.75
71 Medicaid Coverage Expansions and Cigarette Smoking Cessation Among Low-income Adults. Med Care 2017 0.75
72 The evolution of quality management in state Medicaid agencies: a national survey of states with comprehensive managed care programs. Jt Comm J Qual Improv 2002 0.75